AzTrials
AzTrials

SpeechAV-SSR-INCT06282289

Elicitation of Steady-state Audiovisual Responses in 6- and 10-month-old Infants

A study testing Magnetoencephalography (MEG) and Cognition development questionnaire in people with Speech, run by Institut Pasteur.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to investigate the preferential responses of speech neural systems in infants. The main question it aims to answer is to determine whether the oscillatory synchronization capacity is associated with children's language level (i.e. vocabulary). Read more about this study

Who is it for?
Ages 6 to 10 monthsHealthy volunteers can take part
Conditions the study is for
Speech
What is being tested?
Magnetoencephalography (MEG) and Cognition development questionnaire
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
No sites listed yet
Study dates
May 2025to 21 Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 10 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • be 6 or 10 months old (+/- 2 weeks)
  • have received age-appropriate information on the experiment
  • their legal guardians have received appropriate information and given their oral consent.

Who cannot join

  • A neurological disorder (visual, auditory, motor, executive)
  • Developmental delay

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

The goal of this study is to investigate the preferential responses of speech neural systems in infants.

The main question it aims to answer is to determine whether the oscillatory synchronization capacity is associated with children's language level (i.e. vocabulary).

Participants will be presented with synthetically modulated stimuli at three frequency scales: 4 Hz, 5 Hz and 30 Hz.

Conditions
Speech
Being tested
Magnetoencephalography (MEG), Cognition development questionnaire
Medical subject headings
Speech

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Magnetoencephalography (MEG)Behavioural

    Stimuli will be presented binaurally through headphones at 60 decibel sound pressure level (dB SPL). Conditions are presented in a pseudo-random order with an inter-stimulus interval of ~800 ms on average (range: 600 ms to 1000 ms). The duration of the stimuli is fixed: 2 seconds, in order to guarantee a minimum number of cycles.

  • Cognition development questionnaireOther

    Computerised questionnaires completed by parents

Study groups in NCT06282289
Study groupRoleWhat they receive
6-month-old infantsOtherNot described
Receives: Behavioral: Magnetoencephalography (MEG); Other: Cognition development questionnaire
10-month-old infantsOtherNot described
Receives: Behavioral: Magnetoencephalography (MEG); Other: Cognition development questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Significance of correlation between the delta (i.e. difference) of synchronization power estimated at 10- and 6-months of age and the delta of vocabulary level measured at 18months of age.

    Measured: at 10-months, 6-months and 18-months of age

Secondary outcomes (2)
  1. The equation for linear regression analysis used to estimate the amount of neuronal synchronization between auditory and visual perception systems according to the Coherence and the Synchrony of AV inputs

    Measured: at 10- and 6-months of age

  2. The equation for linear regression analysis used to estimate the variation in the amount of neuronal synchronization between 4 experimental conditions according to the Coherence and the Synchrony of AV inputs

    4 experimental conditions : AV synchronous coherent, AV asynchronous coherent, AV synchronous incoherent, and AV asynchronous incoherent

    Measured: at 10- and 6-months of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2024
  2. Study startMay 2025 (estimated)
  3. Primary completion21 Sep 2025 (estimated)
  4. Study completion21 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06282289
Sponsor's protocol ID
2023-077
Other IDs
2023-A01798-37
Acronym
AV-SSR-I
Status last verified
Feb 2025
First submitted
18 Dec 2023
Last updated
3 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Magnetoencephalography (MEG) and Cognition development questionnaire in people with Speech, run by Institut Pasteur.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sophie Bouton, PhD (0176535072 ext. +33, sophie.bouton@pasteur.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Significance of correlation between the delta (i.e. difference) of synchronization power estimated at 10- and 6-months of age and the delta of vocabulary level measured at 18months of age. (time frame: at 10-months, 6-months and 18-months of age). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in